Anti-Recombinant GLP-1, clone A229
| Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
|---|---|---|---|---|---|---|---|
| E-AN301530L.50 | 50 µl | - |
7 - 16 business days* |
304.00€
|
|||
| E-AN301530L.100 | 100 µl | - |
7 - 16 business days* |
464.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by... more
Product information "Anti-Recombinant GLP-1, clone A229"
Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes.
| Keywords: | Anti-GCG, Anti-Pro-glucagon, Recombinant GLP-1 Monoclonal Antibody |
| Supplier: | Elabscience |
| Supplier-Nr: | E-AN301530L |
Properties
| Application: | WB, IHC, IF, FCM |
| Antibody Type: | Monoclonal |
| Clone: | A229 |
| Conjugate: | No |
| Host: | Rabbit |
| Species reactivity: | human, rat, mouse |
| Immunogen: | Recombinant human GLP-1 fragment |
| MW: | 11 kD |
Database Information
| KEGG ID : | K05259 | Matching products |
| UniProt ID : | P01275 | Matching products |
| Gene ID : | GeneID 2641 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | -20°C (International: -20°C) |
| Signal Word: | Warning |
| GHS Hazard Pictograms: |
|
| H Phrases: | H317 |
| P Phrases: | P261, P272, P280, P302+352, P333+313 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed